Bringing song into speech therapy could strengthen patients’ voice
Combining a singing program with conventional speech therapy could help to lessen the vocal problems facing people with Parkinson’s…
Articles by Marisa Wexler, MS
Kynmobi to be discontinued in US and Canada due to limited use
Kynmobi (apomorphine hydrochloride), an under-the-tongue therapy approved to help manage off episodes in Parkinson’s disease, is being discontinued…
Report points to limited benefits of SSRIs in elderly patients
Use of certain anti-depressants may increase the risk of life-threatening clotting problems in elderly people with Parkinson’s disease, a…
LUMA trial expands to patients with LRRK2 gene mutation
The Phase 2 LUMA clinical trial, which is testing the experimental LRRK2 inhibitor BIIB122 in people with Parkinson’s disease,…
Patients often start antipsychotics soon after being hospitalized
Many people with Parkinson’s disease who take antipsychotic medications begin them shortly after being hospitalized, a new study shows.
Brain damage patterns differ in patients with, without RBD: Study
Patterns of brain damage in Parkinson’s disease differ based on whether or not individuals have REM sleep behavior disorder…
Digital tool shortens time of initial programming for DBS
A new digital tool called MAP DBS may help improve the efficiency of deep brain stimulation (DBS) for people with…
Wearable cyborgs improve walking for Parkinson’s patients: Study
Several people with Parkinson’s disease were able to improve their ability to walk by using a “wearable cyborg” over their…
Virtual music therapy benefits Parkinson’s patients and caregivers
A 12-week virtual music therapy program was found to reduce apathy and depression among people with Parkinson’s disease —…
New webinar to focus on TCE chemical and Parkinson’s disease
At an upcoming free webinar, hosted by Synapticure, experts will discuss how the chemical trichloroethylene or TCE — a widely-used…